Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 06 2022
Historique:
received: 19 08 2021
accepted: 23 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Chronic Levodopa therapy, the gold-standard treatment for Parkinson's Disease (PD), leads to the emergence of involuntary movements, called levodopa-induced dyskinesia (LID). Cerebellar stimulation has been shown to decrease LID severity in PD patients. Here, in order to determine how cerebellar stimulation induces LID alleviation, we performed daily short trains of optogenetic stimulations of Purkinje cells (PC) in freely moving LID mice. We demonstrated that these stimulations are sufficient to suppress LID or even prevent their development. This symptomatic relief is accompanied by the normalization of aberrant neuronal discharge in the cerebellar nuclei, the motor cortex and the parafascicular thalamus. Inhibition of the cerebello-parafascicular pathway counteracted the beneficial effects of cerebellar stimulation. Moreover, cerebellar stimulation reversed plasticity in D1 striatal neurons and normalized the overexpression of FosB, a transcription factor causally linked to LID. These findings demonstrate LID alleviation and prevention by daily PC stimulations, which restore the function of a wide motor network, and may be valuable for LID treatment.

Identifiants

pubmed: 35680891
doi: 10.1038/s41467-022-30844-0
pii: 10.1038/s41467-022-30844-0
pmc: PMC9184492
doi:

Substances chimiques

Antiparkinson Agents 0
Levodopa 46627O600J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3211

Informations de copyright

© 2022. The Author(s).

Références

Nat Neurosci. 2006 Mar;9(3):389-97
pubmed: 16474392
PLoS One. 2016 Nov 16;11(11):e0165887
pubmed: 27851801
J Neurosci. 2010 May 26;30(21):7335-43
pubmed: 20505100
Neuron. 2019 May 8;102(3):636-652.e7
pubmed: 30905392
Cerebellum. 2015 Feb;14(1):47-9
pubmed: 25283181
Eur J Neurosci. 1996 Feb;8(2):365-81
pubmed: 8714707
Neurobiol Dis. 2007 May;26(2):452-63
pubmed: 17350277
Neurobiol Dis. 2014 Nov;71:334-44
pubmed: 25171793
Brain Stimul. 2019 Nov - Dec;12(6):1517-1525
pubmed: 31217080
Nat Neurosci. 2011 Mar;14(3):357-65
pubmed: 21297628
Nat Neurosci. 2014 Sep;17(9):1233-9
pubmed: 25064850
Nature. 2018 May;557(7704):177-182
pubmed: 29720658
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16223-8
pubmed: 24046366
Elife. 2020 Jul 08;9:
pubmed: 32639229
Neurobiol Dis. 2011 Jun;42(3):327-40
pubmed: 21310234
Neurobiol Dis. 2006 Jun;22(3):586-98
pubmed: 16531050
Sci Adv. 2019 Oct 30;5(10):eaav9847
pubmed: 31692960
J Neurophysiol. 2001 Nov;86(5):2489-504
pubmed: 11698537
Parkinsonism Relat Disord. 2012 Jan;18(1):59-62
pubmed: 21920793
Brain. 2006 Jul;129(Pt 7):1748-57
pubmed: 16684788
J Pharmacol Exp Ther. 2007 Oct;323(1):277-84
pubmed: 17660384
Nat Rev Neurosci. 2008 Sep;9(9):665-77
pubmed: 18714325
Cell Rep. 2018 May 29;23(9):2690-2704
pubmed: 29847799
Neuroscience. 1994 May;60(1):125-32
pubmed: 8052406
Brain Stimul. 2016 May-Jun;9(3):323-335
pubmed: 26947241
Prog Brain Res. 2000;124:141-72
pubmed: 10943123
Nat Commun. 2018 Aug 7;9(1):3133
pubmed: 30087345
Neurobiol Dis. 2019 Dec;132:104579
pubmed: 31445160
Mov Disord. 2001 Mar;16(2):208-16
pubmed: 11295772
Nat Neurosci. 2006 Oct;9(10):1321-9
pubmed: 16964249
Neurology. 2009 Jul 14;73(2):113-9
pubmed: 19597133
Eur J Neurosci. 2004 Mar;19(5):1267-77
pubmed: 15016084
Nat Commun. 2020 May 13;11(1):2388
pubmed: 32404907
Elife. 2020 Mar 17;9:
pubmed: 32180549
J Neurophysiol. 1996 May;75(5):1806-14
pubmed: 8734581
Nat Neurosci. 2014 Dec;17(12):1767-75
pubmed: 25402853
Cerebellum. 2010 Sep;9(3):352-74
pubmed: 20396983
Neuron. 2005 Mar 24;45(6):953-65
pubmed: 15797555
Neurobiol Dis. 2002 Jul;10(2):165-86
pubmed: 12127155
Mov Disord. 2018 Jul;33(6):889-899
pubmed: 29488257
Neurobiol Dis. 2004 Jun;16(1):110-23
pubmed: 15207268
Sci Rep. 2018 Jul 3;8(1):10068
pubmed: 29968767
Cereb Cortex. 2013 Feb;23(2):305-14
pubmed: 22351647
Science. 2009 Apr 17;324(5925):354-9
pubmed: 19299587
J Neurosci. 2005 Dec 7;25(49):11279-87
pubmed: 16339023
J Neural Transm. 1984;59(3):229-40
pubmed: 6429277
Trends Neurosci. 2004 Sep;27(9):520-7
pubmed: 15331233
Neurosci Lett. 2020 Jan 18;716:134653
pubmed: 31778767
Cereb Cortex. 2014 Aug;24(8):2055-67
pubmed: 23535177
J Neurosci. 2003 Sep 10;23(23):8432-44
pubmed: 12968006
Nat Neurosci. 2016 Jun 28;19(7):868-75
pubmed: 27351172
Cell Rep. 2018 Jun 19;23(12):3438-3446.e5
pubmed: 29924988
J Neurosci. 2006 Aug 2;26(31):8101-14
pubmed: 16885224
Postgrad Med J. 2007 Jun;83(980):384-8
pubmed: 17551069
Neuron. 2005 Jan 20;45(2):201-6
pubmed: 15664172
J Neurosci. 1996 Oct 15;16(20):6579-91
pubmed: 8815934
J Neurosci. 2012 Nov 21;32(47):16541-51
pubmed: 23175810
Nat Neurosci. 2003 May;6(5):501-6
pubmed: 12665799
Front Neurol. 2014 Aug 18;5:157
pubmed: 25183959
J Neurosci. 2013 May 29;33(22):9353-63
pubmed: 23719804
Brain Stimul. 2014 Sep-Oct;7(5):643-9
pubmed: 24924734
Biol Psychiatry. 2006 Jan 1;59(1):64-74
pubmed: 16139809
Neurobiol Dis. 2014 Feb;62:179-92
pubmed: 24103779
Front Neurol. 2014 May 06;5:68
pubmed: 24834063
Front Neurosci. 2007 Oct 15;1(1):211-23
pubmed: 18982130
J Neural Transm (Vienna). 2018 Aug;125(8):1157-1169
pubmed: 29704061
Cerebellum. 2016 Feb;15(1):43-47
pubmed: 26542731
Nat Commun. 2021 Feb 26;12(1):1295
pubmed: 33637754
Brain Res. 2000 Oct 13;880(1-2):191-7
pubmed: 11033006
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18664-18672
pubmed: 31455727
Brain. 1998 Mar;121 ( Pt 3):527-33
pubmed: 9549528
Neurobiol Dis. 1999 Dec;6(6):461-74
pubmed: 10600402
Elife. 2018 Apr 16;7:
pubmed: 29659351
Nat Neurosci. 2018 Sep;21(9):1281-1289
pubmed: 30127430
Mov Disord. 2015 Jan;30(1):80-9
pubmed: 25488260
J Parkinsons Dis. 2011;1(4):347-57
pubmed: 23933656
Biol Psychiatry. 2009 Sep 15;66(6):554-61
pubmed: 19481198
Biol Psychiatry. 2016 Mar 1;79(5):354-361
pubmed: 25146322
Mov Disord. 2001 May;16(3):448-58
pubmed: 11391738
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8452-6
pubmed: 20404184
Neuroscience. 1999;94(2):515-27
pubmed: 10579213
J Comp Neurol. 1994 Nov 8;349(2):165-81
pubmed: 7860776
Cereb Cortex. 2019 Apr 1;29(4):1752-1766
pubmed: 30715237
J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):308-14
pubmed: 10449551
Brain Stimul. 2014 Jan-Feb;7(1):13-20
pubmed: 24126192
J Neural Transm (Vienna). 2018 Aug;125(8):1171-1186
pubmed: 29396608
Nat Rev Neurosci. 2009 Sep;10(9):670-81
pubmed: 19693030
Nat Neurosci. 2005 Nov;8(11):1491-3
pubmed: 16205719
Neurobiol Dis. 2015 Oct;82:200-212
pubmed: 26093171
J Neurosci. 2005 Feb 23;25(8):2102-7
pubmed: 15728850
Brain Struct Funct. 2015 Nov;220(6):3595-609
pubmed: 25124274
Neuroscience. 2015 Dec 3;310:12-26
pubmed: 26363150
Brain. 2006 Apr;129(Pt 4):1059-69
pubmed: 16476674
Neuron. 2018 Feb 21;97(4):787-795.e6
pubmed: 29398356

Auteurs

Bérénice Coutant (B)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France.

Jimena Laura Frontera (JL)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France.

Elodie Perrin (E)

Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.

Adèle Combes (A)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France.

Thibault Tarpin (T)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France.

Fabien Menardy (F)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France.

Caroline Mailhes-Hamon (C)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France.

Sylvie Perez (S)

Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.

Bertrand Degos (B)

Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.

Laurent Venance (L)

Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.

Clément Léna (C)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France. clement.lena@bio.ens.psl.eu.

Daniela Popa (D)

Neurophysiology of Brain Circuits Team, Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005, Paris, France. daniela.popa@bio.ens.psl.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH